Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	n.A.	n.A.	-15.82
Graham Fair Price	n.A.	n.A.	8.06
PEG	310.75	-0.22	0.05
Price/Book	inf	0.00	1.61
Price/Cash Flow	inf	0.00	9.17
Prices/Earnings	82.39	9.54	5.23
Price/Sales	73.28	9.32	5.38
Price/FCF	inf	0.00	9.17
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	40.55	1.00	0.71
Operating Margin	13.61	0.43	0.38
ROA	inf	0.00	0.01
ROE	0.08	0.00	inf
ROIC	0.07	0.00	inf
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.00	0.00	0.00
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	1.12	-0.31	-72.62
EPS QOQ	0.96	-0.43	-55.60
FCF QOQ	< 0.005	-1.00	-11025.54
Revenue QOQ	1.06	-0.39	-63.11
Naive Interpretation	member

03 - Financial Growth · Bad

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	0.61	0.00	inf
Days Sales Outstanding (DSO)	446.04	n.A.	n.A.
Inventory Turnover	148.41	0.00	inf
Debt/Capitalization	0.14	0.00	inf
Quick Ratio	1.06	0.00	inf
Naive Interpretation	member

04 - Leverage & Liquidity · Not Interpreted

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	6.13	n.A.	n.A.
Cash	27.02	n.A.	n.A.
Capex	-0.22	0.00	inf
Free Cash Flow	1.08	0.00	inf
Revenue	1.83	1.12	-39.07
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.06	0.00	inf
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-27.15	n.A.	n.A.
Naive Interpretation	Member

06 - Financial Health · Not Interpreted

Rating